Patrick Horn is Chief Medical Officer at Albireo. He has extensive drug development experience in both large and small companies. His work in the Biotech industry includes planning and leading successful development programs for therapeutics targeting orphan diseases ranging from Phase 1 through regulatory approval and product launch. He has formal training and extensive experience in clinical pharmacology. Pat received both his MD and PhD from the University of Chicago and completed a Pediatric Residency at Boston Children’s Hospital. Prior to transitioning to industry, Pat was a practicing pediatrician at a major academic institution in Chicago for almost 20 years.